Story
Germany to Block Cosco's Acquisition of Logistics Firm Zippel on Security Grounds

Summary
The German government plans to prohibit the acquisition of an 80% stake in logistics company Zippel by Chinese state-owned shipping giant Cosco, citing national security concerns over strategic dependencies.
The German government intends to block the planned acquisition of logistics firm Zippel by Chinese state-owned shipping company Cosco due to national security concerns. The move reflects a hardening stance in Europe regarding Chinese investment in critical infrastructure.
The Proposed Acquisition
China's state-owned Cosco (SS:601919) was seeking to purchase an 80% stake in the Hamburg-based Zippel, a company specializing in moving shipping containers between seaports and inland destinations. The planned veto was first reported by the German newspaper Handelsblatt, which cited a government memo marked "for official use only."
According to the report, the memo warned that the deal could create strategic dependencies that China might exploit during political conflicts. The German economy ministry's investment review reportedly focused on Zippel's software systems and its processing of potentially sensitive supply chain data.
National Security Review
AdWhile Germany’s antitrust authority had approved the transaction in February, it noted that national security issues were not part of its assessment. The government's foreign investment screening process is a separate review designed to protect critical infrastructure and national interests.
This increased scrutiny follows a contentious 2023 decision where the German government approved Cosco's purchase of a minority stake in a Hamburg port container terminal, despite strong opposition from within the ruling coalition. European governments have become increasingly cautious about allowing state-owned Chinese enterprises to gain control over key logistical assets.
Company Responses
Both the German economy ministry and Zippel did not respond to requests for comment on the matter, according to the source report. A Germany-based spokesperson for Cosco stated that the company could not comment until it receives a final, official decision from Berlin.
Read next
More on Stocks
ClearPoint Neuro Stock Plummets 24% on uniQure's Huntington's Trial Setback
Shares of ClearPoint Neuro fell sharply after its partner, uniQure, announced that its experimental gene therapy for Huntington's disease failed to meet its primary goal in a clinical trial, raising concerns about future revenue for ClearPoint's delivery technology.

Webull to Launch No-Code AI Tool for Trade Preparation via Claude, Perplexity
The online brokerage is expanding its cloud-based AI integration, allowing eligible U.S. users to research markets and prepare trades using natural language on platforms like Claude and Perplexity, without any software installation.

Iovance Biotherapeutics Raises Revenue Forecast on Strong Amtagvi Demand, Shares Surge
The biotech company boosted its full-year 2026 revenue guidance by approximately 15% at the midpoint, citing accelerating demand for its cancer therapies Amtagvi and Proleukin.

J.P. Morgan Upgrades Bureau Veritas to Overweight on Growth and M&A Outlook
J.P. Morgan raised its rating on the inspection and certification firm to “Overweight,” citing an expected recovery in organic growth driven by data centers and an increased capacity for acquisitions.